Trilaciclib Linked to Lower Severe Myelosuppression in Esophageal Cancer Cohort
A prospective observational cohort study found that trilaciclib use was associated with lower rates of severe chemotherapy-induced myelosuppression in patients ...
A prospective observational cohort study found that trilaciclib use was associated with lower rates of severe chemotherapy-induced myelosuppression in patients ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.